Bank of New York Mellon Corp
BankPosition in PTGX — Protagonist Therapeutics, Inc
CIK 1390777
NEW YORK, NY
Position in PTGX
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$43,920,411
+$7,930,003 QoQ
Shares Held
358,300
+4.9% QoQ
Ownership
0.554%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#35
of 341 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 94%
Shared 0%
None 6%
Common Shares in PTGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Bank of New York Mellon Corp holds $4,845,290,998 across 311 Biotechnology names. PTGX ranks #25 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,672,623 | $830,842,010 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
758,492 | $472,950,091 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,578,013 | $380,253,782 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
492,071 | $148,128,128 | |
| 5 | INSM |
INSMED Inc
|
1,312,756 | $139,966,036 | |
| 6 | MRNA |
Moderna, Inc.
|
1,701,675 | $119,168,293 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
601,056 | $112,565,759 | |
| 8 | INCY |
Incyte Corp
|
972,825 | $110,279,435 |
All Filings in PTGX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $43,920,411 | 358,300 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $35,990,408 | 341,465 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $30,602,883 | 350,388 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $24,131,424 | 363,261 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $21,449,287 | 388,082 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $18,225,091 | 376,863 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $15,084,414 | 390,788 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $16,034,985 | 356,333 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $7,078,958 | 204,299 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $5,416,678 | 187,234 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $4,658,846 | 203,177 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $3,360,085 | 201,444 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $5,512,260 | 199,575 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $3,876,259 | 168,533 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $1,792,783 | 164,325 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,332,436 | 158,059 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,123,781 | 142,071 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $3,309,728 | 139,769 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $4,736,494 | 138,494 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $2,323,675 | 131,133 | Shares | Defined | 2021-11-18 | |
| 2021-06-30 | $6,567,289 | 146,330 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $3,460,109 | 133,595 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $2,606,767 | 129,304 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $1,846,574 | 94,454 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $1,789,876 | 101,352 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $590,095 | 83,583 | Shares | Defined | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||